Together, they provide comprehensive support for energy, metabolism, and overall wellness
Neurodegeneration Alzheimers disease and dementia A review of 15 randomized controlled trials including over 2,400 subjects found that higher doses of Cerebrolysin were associated with reduced psychological symptoms and potentially slower progression in patients with Alzheimers disease and dementia
However, multiple forces are converging to limit their future: 1
In fasted healthy normal weight patients, GLP-1 (7-36) amide injection reduced fMRI activity induced by food images, in all brain areas studied (amygdala, insula, caudate, NAc, orbitofrontal cortex, and putamen), compared to saline injection [43]